Articles

Even as the minimum wage ticks up in 25 states, inflation remains high and competition for better-paying jobs is increasing.

Forget about the Magnificent Seven and AI. The stocks that did the absolute best during the year were tied to biotech and crypto — along with one car-related company.

A weekly look at the most important moves and news in crypto and what's on the horizon in digital assets.

Iovance Biotherapeutics Inc.'s stock fell sharply on heavier-than-usual volume on Wednesday, after the cancer-therapy company said the U.S. Food and Drug Administration placed a clinical hold on its trial for the lung-cancer treatment IOV-LUN-202.

"It appears that had I had more in stocks, I would have made more money over the past couple of years."

Bond prices narrow between 10-year Treasurys and all but two of the seven largest S&P 500 components.

U.S. bond yields fell on Wednesday as investors continued to price in interest rate cuts by the Federal Reserve in 2024.

An equalweight measure of the S&P 500 logged a 'golden cross,' signaling the potential for more gains as beatdown parts of the market play catch-up.

Tesla faces a "volatile, idiosyncratic year" with no new products and increased competition, Morgan Stanley says.

Post Content

New year, higher expenses? Rising cost of living is scaring some Americans looking to save for retirement.

If interest rates follow predictions and keep falling in 2024, you can expect annuity payout yields to plunge further, too.